June 25 - 29, 2010, Orlando, Florida
Program Information
Meeting Overview
The program will begin on Friday, June 25 at 2:00 p.m. and conclude on Tuesday, June 29 at 12:15 p.m. Program content is organized into eight theme areas.
Program Theme Areas
Major Lectures
- Banting Medal for Scientific Achievement Lecture
- Outstanding Scientific Achievement Award Lecture
- Outstanding Educator in Diabetes Award Lecture
- President, Health Care & Education Address
- President, Medicine & Science Address
- Kelly West Award for Outstanding Achievement in Epidemiology Lecture
- Behavioral Medicine & Psychology Interest Group for Distinguished Contributions
- Edwin Bierman Lecture
- Roger Pecoraro Lecture
- Norbert Freinkel Lecture
Poster Sessions
Each year, the best new basic and clinical science related to diabetes and its complications is presented at the Scientific Sessions. Over 1,500 posters will be available for viewing in the Poster Hall. All posters will be available for viewing June 26-28 and will remain up for three days. Poster presenters will be scheduled to be at their poster boards to discuss their research for two hours on an assigned day.
Abstract Book
The Scientific Sessions Abstract Book, the June 2010 supplement to the journal Diabetes, will be provided free of charge at the meeting to all attendees.
Exhibit Hall
Plan to visit the world’s largest exposition of diabetes-related products, services, and technology. More than 175 companies will showcase the newest and most innovative products and services available to health care professionals. The Exhibit Hall will be open Saturday and Sunday, June 26-27, from
10:00 a.m. to 4:00 p.m., and Monday, June 28 from 10:00 a.m. to 2:00 p.m.
Session Titles*
*Session titles are current as of 10/5/09. Sessions have not been finalized and are subject to change.
Click here for a brief description of session formats.
Acute and Chronic Complications
Symposia
-
Lipids – Key Issues in the Management of Dyslipidemia
-
Complications of Diabetes – What Is Unique about the Retina?
-
Update on Diabetic Peripheral Neuropathy
-
Team Building to Prevent Amputations
-
Vascular, Infection, Pressure – The VIPs of Healing Diabetic Wounds
-
Controversies in Blockade of the Renin-Angiotensin-Aldosterone System (RAAS)
-
Does Diabetes Affect the Approach to Diagnosis or Management of Cardiovascular Disease?
-
Cardiorenal Issues in Diabetes Management
-
Cardiovascular Risks of Hypoglycemia
-
Cardiovascular Disease in Diabetes – Is It Different Than in Non-Diabetes?
-
Physiological Aspects of Hypoglycemia
Back to top
Behavioral Medicine, Clinical Nutrition, Education, & Exercise
Symposia
-
Diabetes Prevention and Behavioral Interventions in Underserved Populations
-
From Children to Adults – Models of Transition Care in Youth with Diabetes
-
Advancing the Field – The Role of Inflammation in Depression and Diabetes
-
Who Can Help My Diabetes Patient? Behavioral Strategies and Shared Medical Appointments
-
Type 2 Diabetes, Exercise, and Cerebrovascular Physiology
-
Practical Issues in Diabetes and Exercise
-
Prescribing Exercise for Severely Obese Patients
-
Non-Caloric/Non-Nutritive Sweeteners – What’s New?
-
Cardiovascular Disease and Diabetes – Nutrition Update
-
What Influences How Much We Eat?
-
Dietary Sweeteners Containing Fructose – Effects on Metabolism and Impact in the Food Supply
-
The Art and Science of Gestational Diabetes Counseling
-
Lost in Translation
-
Complementary and Alternative Medicine Supplements and Diabetes Care
-
New Technologies for Diabetes Education and Management
Back to top
Clinical Diabetes/Therapeutics
Current Issues
-
Will DPP-4 Inhibitors Replace Sulfonylureas?
-
Is Intensively Treated Type 1 Diabetes Still a Major Cardiovascular Risk Factor?
-
Glycemic Outcomes and Acute Complications MDI and Pump Therapy Issues and Solutions
-
Should New Diabetes Drugs Submitted to the FDA Have a Higher Bar for Cardiovascular Safety Than Other Drugs?
Symposia
-
Combination Therapies for Type 2 Diabetes from the Get Go – Are We There Yet?
-
Intensive Insulin Therapy at the Onset of Type 2 Diabetes – Can We Preserve Beta Cell Function and Reverse Diabetes?
-
Controversies Relating Cancer with Diabetes, Obesity, and Insulin
-
Tactics and Controversies in the Management of Hyperglycemia in the Hospital
-
The Potential of SGLT-2 Inhibitors for Diabetes Management
-
Joint American Diabetes Association/Juvenile Diabetes Research Foundation Symposium – The Artificial Pancreas – A Goal within Reach?
-
Clinical Role of TZDs in 2010
-
Managing Insulin Therapy in the Obese, Extremely Insulin Resistant Patient
-
Newer Insulins – As They Approach Availability What Should We Know about Them?
-
Updates on GLP-1 Agonists
-
Diabetes in the New Realm of Comparative Effectiveness Research
-
The Implications of U.S. Health Care Reform on the Care and Prevention of Diabetes
-
A1C Targets in Pediatric Diabetes – Ideal vs. Real
-
A 21st Century Look at Genetic Causes of Diabetes and Its Complications in Youth
-
Pediatric Diabetes Trends – Epidemiology 2010
-
Drug Therapy During Pregnancy – Safety and Effectiveness
-
Pregnancy Diet and Supplements – Needs and Concerns
-
Pregnancy and Diabetes Research – A 20-Year Tribute to Norbert Freinkel
-
Tailoring Diabetes Treatment Priorities in the New Age of Cardiometabolic Risk Management
Back to top
Epidemiology/Genetics
Current Issues
Symposia
- Diabetes Diagnosis Based on the A1C
- Stages of the Lifecycle and Risk for Onset and Progression of Diabetes and Its Complications
- The Role of Sex Hormones in the Epidemiology of Type 2 Diabetes and Cardiometabolic Risk
- From Genetic Association to Molecular Mechanism
- Clinical Impact of the New Genetic Discoveries in Diabetes
- Beyond the First Phase of Genome Wide Association Studies
Back to top
Immunology/Transplantation
Symposia
- Alternative Cellular Sources for Beta Cell Replacement Therapy – Today and Tomorrow
- Nanotechnology and Tissue Engineering for Beta Cell Replacement Therapy
- B Cells in Type 1 Diabetes Mellitus
- Innate Immune Responses in Type 1 and Type 2 Diabetes
Back to top
Insulin Signaling/Insulin Action
Symposia
- Cross-Talk in Insulin Signaling at the Cellular Level
- Thyroid Hormone Signaling in Insulin Action and Metabolism
- Insulin Action – A Molecular View
- Selective Hepatic Insulin Resistance
- Mitochondrial Metabolism and Substrate Selection
- Novel Insights into Insulin Resistance and Metabolic Syndrome
- Clues on Mechanisms of Insulin Resistance from Other Human Syndromes
- Control of Adipose Tissue Development and Function
Back to top
Integrated Physiology or Obesity
Symposia
- Inflammation and Free Fatty Acids in Glucose Homeostasis
- Epigenetics and Metabolic Disease
- Glucagon-Like Peptide-1 – From Secretion to Function
- Bile Acids as Metabolic Regulators
- Central Modulators of Obesity
- Nutrient-Gut-Brain Modulators
- Adipose Tissue and Inflammation
- Role of the Kidney in the Pathogenesis of Type 2 Diabetes Mellitus
- What Has Genetics Taught Us? From Gene to Human Physiology
- Brown Adipose Tissue
- Beta Cell Failure – The Key to Unlocking Type 2 Diabetes Mellitus
Back to top
Islet Biology/Insulin Secretion
Symposia
- Does Autoimmunity Influence Beta Cell Regeneration?
- Transdifferentiation and Reprogramming
- Pathways to Beta Cell Development and Differentiation
- Mitochondria, Endoplasmic Reticulum and Oxidative Stress, and Beta Cell Survival
- Beta Cell Intracellular Signaling-1 – mTor to S6Kinase
- Beta Cell Intracellular Signaling-2 – PI3Kinase and PKCs, and IKKs
- Beta Cell Intracellular Signaling-3 – A Potpourri
- Insulin Secretion
Back to top